SpyGlass Pharma, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Dec 2023 | — | $-33.0M | $15.8M |
| Dec 2024 | — | $-60.5M | $16.3M |
| Mar 2025 | — | $-68.9M | $58.0M |
| Jun 2025 | — | $-78.4M | $127.2M |
| Dec 2025 | — | $-98.8M | $96.4M |
| Mar 2026 | — | $250.1M | $238.9M |
| Jun 2026 | — | $232.4M | $223.1M |